Categories: All postsAnalysts

Bombardier is still a gamble, this fund manager says

Michael Decter

Bombardier’s (Bombardier Inc. Stock Quote, Chart, News: TSX:BBD.B) fortunes may have improved as of late, but don’t expect unlimited growth from the stock, says Michael Decter of LDIC Inc., who argues that the aerospace and transport company remains an investment gamble.

These days, Bombardier’s share price certainly looks better than it did a couple of years ago, when it bottomed out at $0.72 in February of 2016. Now nipping at $5.00, the stock is prompting investors to wonder how much higher can it go.

Maybe not so much more, says Decter, who cautions that the jury is out on the company’s C Series deal with Airbus, which will see the European plane maker take over production of Bombardier’s C Series jetliner, starting July 1.

“We bought [Bombardier stock] a few times and lost our nerve when it did a swan dive. I’ve started to look at it over the last few weeks and I’m starting to see analysts with $6.00 targets on it,” Decter told BNN Bloomberg Monday.

“There are some big, big moving pieces,” says Decter. “One presumes that Airbus knows how to make planes and that they’ll bring some large plane experience to bear, which should be good. How much juice is left in that deal for Bombardier is hard to tell. It’s a great plane but is it a great business?”

Last week, Bombardier lowered its revenue forecast for 2018 even as it said C Series deliveries are expected to double this year. News also broke that Bombardier is launching two new large-cabin business-class planes, the Global 5500 and the Global 6500 aircrafts, as part of the company’s intended pivot towards luxury aircraft and trains.

“I’m cautious,” says Decter. “If I had an average price of $2.50 a share, I would probably start trimming it gently above $5.00 and heavily if it gets above $6.00. I wouldn’t sell it all, but I would take some profits.”

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: bbd.b
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

23 hours ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

23 hours ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

1 day ago

Rogers is an undervalued stock, RBC says

With the integration of Shaw Communications underway, RBC analyst Drew McReynolds says Rogers Communications (Rogers Communications Stock Quote, Chart, News,… [Read More]

2 days ago

Tornado Global Hydrovacs is still a double, Beacon says

Following fourth quarter results he describes as "stronger than expected", Beacon Securities analyst Russell Stanley has raised his price target… [Read More]

2 days ago

Sell your Molson Coors stock, Citi says

Ahead if its first quarter results, Citi analyst Filippo Falorni says there is not much to like about Molson Coors… [Read More]

3 days ago